Zhonghong Pulin Medical Products Future Growth
Future criteria checks 0/6
Zhonghong Pulin Medical Products is forecast to grow revenue at 10.2% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment earnings growth | 26.5% |
| Revenue growth rate | 10.2% |
| Future return on equity | 3.9% |
| Analyst coverage | Low |
| Last updated | 29 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Zhonghong Pulin Medical Products Co., Ltd.'s (SZSE:300981) Price Is Right But Growth Is Lacking After Shares Rocket 29%
Nov 19
Zhonghong Pulin Medical Products Co., Ltd.'s (SZSE:300981) Revenues Are Not Doing Enough For Some Investors
Sep 25Is Zhonghong Pulin Medical Products (SZSE:300981) Using Too Much Debt?
Jun 28There Is A Reason Zhonghong Pulin Medical Products Co., Ltd.'s (SZSE:300981) Price Is Undemanding
Mar 21Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2,993 | N/A | N/A | 507 | 1 |
| 12/31/2025 | 2,739 | N/A | N/A | 432 | 1 |
| 12/31/2024 | 2,491 | N/A | N/A | 607 | 1 |
| 9/30/2024 | 2,362 | -89 | -105 | -30 | N/A |
| 6/30/2024 | 2,255 | -93 | -185 | -82 | N/A |
| 3/31/2024 | 2,218 | -123 | 36 | 140 | N/A |
| 12/31/2023 | 2,105 | -131 | -61 | 42 | N/A |
| 9/30/2023 | 1,934 | 37 | -60 | 46 | N/A |
| 6/30/2023 | 1,648 | -11 | -142 | -10 | N/A |
| 3/31/2023 | 1,432 | -1 | -125 | 28 | N/A |
| 1/1/2023 | 1,573 | 67 | -101 | 107 | N/A |
| 9/30/2022 | 1,795 | 57 | 169 | 641 | N/A |
| 6/30/2022 | 2,186 | 326 | 323 | 836 | N/A |
| 3/31/2022 | 3,209 | 1,001 | 755 | 1,396 | N/A |
| 1/1/2022 | 4,909 | 2,342 | 1,384 | 2,362 | N/A |
| 9/30/2021 | 6,173 | 3,384 | 1,629 | 2,518 | N/A |
| 6/30/2021 | 7,290 | 4,289 | 2,624 | 3,574 | N/A |
| 3/31/2021 | 6,722 | 4,011 | 2,764 | 3,592 | N/A |
| 12/31/2020 | 4,778 | 2,664 | 2,290 | 2,720 | N/A |
| 12/31/2019 | 1,171 | 89 | 34 | 184 | N/A |
| 12/31/2018 | 968 | 57 | -179 | 24 | N/A |
| 6/30/2018 | 995 | 56 | N/A | 93 | N/A |
| 3/31/2018 | 973 | 61 | N/A | 95 | N/A |
| 12/31/2017 | 951 | 65 | N/A | 96 | N/A |
| 9/30/2017 | 895 | 60 | N/A | N/A | N/A |
| 6/30/2017 | 839 | 55 | N/A | 36 | N/A |
| 3/31/2017 | 775 | 46 | N/A | 69 | N/A |
| 12/31/2016 | 710 | 38 | N/A | 102 | N/A |
| 9/30/2016 | 654 | 36 | N/A | N/A | N/A |
| 6/30/2016 | 598 | 34 | N/A | 91 | N/A |
| 3/31/2016 | 601 | 38 | N/A | 92 | N/A |
| 12/31/2015 | 604 | 42 | N/A | 92 | N/A |
| 9/30/2015 | 617 | 42 | N/A | 132 | N/A |
| 6/30/2015 | 630 | 43 | N/A | 172 | N/A |
| 3/31/2015 | 615 | 34 | N/A | 152 | N/A |
| 12/31/2014 | 585 | 25 | N/A | 133 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 300981's forecast earnings growth is above the savings rate (2.8%).
Earnings vs Market: Insufficient data to determine if 300981's earnings are forecast to grow faster than the CN market
High Growth Earnings: Insufficient data to determine if 300981's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300981's revenue (10.2% per year) is forecast to grow slower than the CN market (13.8% per year).
High Growth Revenue: 300981's revenue (10.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300981's Return on Equity is forecast to be low in 3 years time (3.9%).